Top Five IVD Segments in the United States - Leaders in Forecast Growth

Top Five IVD Segments in the United States - Leaders in Forecast Growth

( This post represents the second installment of a weekly preview of Kalorama Information’s upcoming publication - The US Market for In Vitro Diagnostic Tests - for March 2014. The posts review the projected top-performing IVD segments in the U.S. market through 2018. )

The United States is the most mature and diversified IVD market in the world, with many clinical tests first developed and approved in the country and most core testing segments already at market saturation. Established market ...


Pediatric Warning On Retail Clinics May Be Unnecessary

Pediatric Warning On Retail Clinics May Be  Unnecessary

Recently the American Academy of Pediatrics issued an advisory against bringing small children to retail clinics versus a primary physician for care, but Kalorama’s recent survey suggests US consumers may be viewing clinics as adult zones in any case. The association is worried about maintaining continual patient care if a patient visits many sources of care. http://www.reuters.com/article/2014/02/24/us-health-kids-retail-clinics-idUSBREA1N0ZU20140224. This is a valid concern in theory, but our ...


World Molecular Testing Market: For Growth, See Emerging Nations

World Molecular Testing Market: For Growth, See Emerging Nations

Worldwide, clinical molecular diagnostics is seeing steady but slower growth than some expectations, according to our latest Six Month Update on Molecular Diagnostics. We estimate 5% market growth from 2012 to 2013. Still better than the IVD market as a whole, but representative of some conservative spending. The financial crisis and economic downturn that began in 2008 and continues to some degree today and has changed consumer behavior. Many patients are forgoing physician consultations in the...

  • by bcarlson@marketresearch.com
  • February 20 2014
  • flu vaccine


Stronger Flu Season Boosted Vaccine Revenue

Stronger Flu Season Boosted Vaccine Revenue

An upcoming report will have good news for manufacuters of flu vaccine: The lull the industry has exeprienced since 2011 may be over. Influenza vaccines generated $3.1 billion in revenues, according to research we’ve conducted for our 2014 survey of the vaccine industry. This is up 13.2% from the prior year on a relatively severe current flu season in the U.S., but of course it’s not like the balooning sales of ’09 or ’10. We will make the finding in our Vaccines 2014 report (The report is due o...


Top Five IVD Segments in the United States - Leaders in Forecast Growth

Top Five IVD Segments in the United States - Leaders in Forecast Growth

The United States is the most mature and diversified IVD market in the world, with many clinical tests first developed and approved in the country and most core testing segments already at market saturation. Established market segments such as clinical chemistry, hematology, urinalysis and over-the-counter (OTC) test products idle relatively in the U.S. market, at 1-3% growth annually, with sales growth dependent upon economic and demographic growth and laboratory re-tooling. At the other end of...

  • by bcarlson@marketresearch.com
  • February 11 2014
  • EMR


Google Enters Healthcare, In a Big Way

Google Enters Healthcare, In a Big Way

Providers who thought healthcare was just another IT market were in for a surprise, one that the world’s largest search engine is taking advantage of. As this Healthcare IT News story, which features Kalorama’s market analysis notes, healthcare IT developers may have been scared by recent HIPPA rules making them responsible for privacy violations. This surprised cloud providers who thought they were merely providing an IT service, with the usual guarantees of performance. Certainly not getting i...

  • by bcarlson@marketresearch.com
  • February 10 2014
  • telemedicine


Kalorama Featured in Modern Healthcare Story on Telemedicine’s ROI

Kalorama Featured in Modern Healthcare Story on Telemedicine’s ROI

Kalorama has noted in recent reports that a key challenge for the PM industry is to prove results to win over payors. Thus the RAND study on telemedicine will be welcome news. The study assessed the utilization of telemedicine services in a commercial insurance plan that offered access 24 hours a day to Teladoc, a Texas-based firm that is one of the largest telehealth providers in the country. The story cited Kalorama’s market estimate for telemedicine in our recent report, Advanced Patient Moni...


CVS Stokes a New Fire - From Tobacco to Patient Care in Post-ACA America

CVS Stokes a New Fire - From Tobacco to Patient Care in Post-ACA America

The recent announcement by U.S. drugstore giant CVS that its locations will phase out sales of tobacco products is, at first blush, jarring - both in terms of the drugstore public image and the company’s own bottom line. Behind the decision, however, is CVS’s recognition of the greater business opportunities opening in the U.S. healthcare system. CVS is already a U.S. retail clinic leader, operating around one out of every two retail clinics in the country. Positioning will be key for CVS and ot...

  • by bcarlson@marketresearch.com
  • February 3 2014


Five Companies Dominate Molecular Diagnostics

Five Companies Dominate Molecular Diagnostics

Sixty Percent of the molecular diagnostics market is owned by five companies, according to our l atest six-month market update in molecular diagnostic s. Roche leads, and the rest of the names won’t suprise: BD, Abbott, Hologic and Qiagen. We think top-tier companies will continue to dominate due to their global reach and multi-segment participation. Simply put, they have the resources to play in all the fields, and they can reach emerging markets faster than smaller concerns. Further, as IVD ma...